Published Date: 02 Mar 2023
High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.
Read Full News1.
Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer
2.
Glioblastoma cells can 'unstick' from their neighbors to become more deadly
3.
Getting More Done With Less Blood.
4.
Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.
5.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
1.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
2.
Circulating Tumor Cells & Platelet Interactions: Crosstalk for Therapeutic Advances
3.
What is Mullerian and How Does it Affect Your Health
4.
The Mystery of Carotid Body Tumors: The Facts You Need to Know
5.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
5.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation